STERO Biotechs - The Team
Mr. David Bassa - CEO
Mr. David Bassa is an experienced and proficient entrepreneur.
David owns a number of pharmaceuticals and drug development companies, led the first Cannabis pharma ‘Exit’ in Israel, founder & Previously CEO of Talent Biotech (SOLD),and other ventures. Main Shareholder of 5 startups in biotech or high technologies. David also Won twice Excellence awards from the president of Israel.
Mr. Ofer Alshech - CFO
An experienced CFO in Public and Private, Multi-Millions & Start-Ups companies with strong organizational skills and extensive experience in financial management. Ofer has vast experience in fundraising from private equity, private investors and IPO. Ofer has deep understanding of business drivers, risks & opportunities. For the last 8 years Ofer served as CFO at “Reshet 13” .
Mr. Guy Defrin - COO
As an experienced COO Guy also Serves as the active COO of CannaLean Biotechs, CannaMore Biotechs, the biotech startup accelerator BioSeedXL and more companies in the pharmaceuticals and Cannabis fields.
Graduated B.Sc. in Biology and life science at Tel Aviv University with specialty in biochemistry research.
Dr. Sari Prutchi Sagiv - CSO
Dr Sagiv brings over 20 years of proven management experience in the fields of clinical development, business development, marketing and intellectual property from the bio-tech and high-tech industries.
Dr. Sagiv also manages the pharma and diagnostics department at Mor Research Applications, the Technology Transfer unit of ‘CLALIT’ Health Services.
Dr. Sagiv holds a PhD in immunology and an MBA from Tel Aviv University.
Dr. Moshe Yeshurun, MD – CTO
Specialist in Internal Medicine, Hematology and Bone Marrow Transplantation. Director of the Bone Marrow Transplantation Unit, Rabin Medical Center, Israel. The inventor of a CBD based drug and IP for treatment of GvHD, sold to the publicly traded Kalytera Therapeutics (TSXV: KALY).
Dr. Naftali Timna, MD - IBD Medical Director
Deputy Director and Specialist in Gastroenterology and liver disease at Meir Hospital and CLALIT. Vast experience in both IBD and Cannabis fields, including research and clinical trials with the collaboration of Tikun Olam.
Prof. Ronit Confino, MD - Urticaria Medical Director
Head of drug allergy service, Allergy and Clinical Immunology Unit, Meir Medical Center
Head of Allergy and Clinical Immunology Unit, Meir Medical Center